Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genentech returns rights to SGN-14 to Seattle Genetics

Oct. 10, 2002

NCI awards SPORE grant for lymphoma research

Oct. 7, 2002

New modulators of immunotherapeutic agents described by Altachem and U. of Alberta

Oct. 7, 2002

Igeneon licenses IGN-301 from Novartis

Oct. 4, 2002

Avax signs distribution agreement with Ferrer for AC Vaccine technology

Oct. 4, 2002

Potential use of the HSPPC-96 vaccine in patients with metastatic renal cell carcinoma

Oct. 4, 2002

Allovectin-7 update

Oct. 1, 2002

Monoclonal antibodies targeting human BST2

Oct. 1, 2002

G17DT granted fast track status for pancreatic cancer

Sep. 27, 2002

Update on phase II and III clinical studies of Theratope in breast cancer

Sep. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...